Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for CNMD

Stock Name	CONMED Corporation
Ticker	CNMD(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US2074101013
LEI	Z6C0YCECH9DCU5ZIQW84

Show aggregate CNMD holdings

News associated with CNMD

CONMED Corporation (NYSE:CNMD) Receives $59.80 Average Price Target from Analysts: CONMED Corporation (NYSE:CNMD – Get Free Report) has received a consensus recommendation of “Hold” from the five research firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that […] - 2025-08-13 03:14:55
Allianz Asset Management GmbH Acquires Shares of 5,300 CONMED Corporation (NYSE:CNMD): Allianz Asset Management GmbH acquired a new stake in CONMED Corporation (NYSE:CNMD – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,300 shares of the company’s stock, valued at approximately $320,000. A number of other hedge funds also […] - 2025-08-04 05:58:48
Victory Capital Management Inc. Has $954,000 Stock Holdings in CONMED Corporation (NYSE:CNMD): Victory Capital Management Inc. grew its position in shares of CONMED Corporation (NYSE:CNMD – Free Report) by 5.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,799 shares of the company’s stock after purchasing an additional 815 shares during the quarter. Victory Capital […] - 2025-08-01 07:06:54
Envestnet Asset Management Inc. Raises Stock Position in CONMED Corporation (NYSE:CNMD): Envestnet Asset Management Inc. grew its holdings in CONMED Corporation (NYSE:CNMD – Free Report) by 6.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 159,750 shares of the company’s stock after acquiring an additional 10,040 shares during the period. Envestnet Asset Management Inc.’s holdings in CONMED were worth $9,647,000 at the end of […] - 2025-07-21 04:47:05
How To YieldBoost CONMED To 16.7% Using Options: Shareholders of CONMED Corp (Symbol: CNMD) looking to boost their income beyond the stock's 1.6% annualized dividend yield can sell the March 2026 covered call at the $55 strike and collect the premium based on the $5.10 bid, which annualizes to an additional 15.1% rate of retur - 2025-07-17 12:43:35
CONMED Corporation (NYSE:CNMD) Shares Sold by M&T Bank Corp: M&T Bank Corp reduced its holdings in CONMED Corporation (NYSE:CNMD – Free Report) by 50.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,668 shares of the company’s stock after selling 8,877 shares during the period. M&T Bank Corp’s holdings in CONMED were […] - 2025-07-17 04:58:56
Oregon Public Employees Retirement Fund Sells 200 Shares of CONMED Corporation (NYSE:CNMD): Oregon Public Employees Retirement Fund lowered its holdings in shares of CONMED Corporation (NYSE:CNMD – Free Report) by 2.8% during the first quarter, Holdings Channel reports. The institutional investor owned 7,069 shares of the company’s stock after selling 200 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in CONMED were worth $427,000 as […] - 2025-07-09 05:34:57
Principal Financial Group Inc. Boosts Stake in CONMED Corporation (NYSE:CNMD): Principal Financial Group Inc. increased its stake in CONMED Corporation (NYSE:CNMD – Free Report) by 1.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 634,677 shares of the company’s stock after buying an additional 9,619 shares during the quarter. Principal Financial Group Inc.’s holdings in CONMED were worth $38,328,000 as of its most […] - 2025-07-07 05:54:48
Illinois Municipal Retirement Fund Reduces Stake in CONMED Corporation (NYSE:CNMD): Illinois Municipal Retirement Fund reduced its position in CONMED Corporation (NYSE:CNMD – Free Report) by 6.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,462 shares of the company’s stock after selling 1,052 shares during the period. Illinois Municipal Retirement Fund’s holdings […] - 2025-07-02 06:00:50
CONMED Corporation (NYSE:CNMD) Shares Sold by Diversified Trust Co: Diversified Trust Co cut its holdings in shares of CONMED Corporation (NYSE:CNMD – Free Report) by 18.6% during the first quarter, HoldingsChannel.com reports. The firm owned 10,800 shares of the company’s stock after selling 2,475 shares during the period. Diversified Trust Co’s holdings in CONMED were worth $652,000 as of its most recent SEC filing. […] - 2025-06-30 05:18:55
CONMED Corporation (NYSE:CNMD) Stake Lifted by QRG Capital Management Inc.: QRG Capital Management Inc. increased its position in shares of CONMED Corporation (NYSE:CNMD – Free Report) by 7.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 5,326 shares of the company’s stock after buying an additional 350 shares during the quarter. QRG Capital Management Inc.’s holdings in CONMED were worth $322,000 at the […] - 2025-06-24 04:46:59
Analysts Set CONMED Corporation (NYSE:CNMD) PT at $62.20: CONMED Corporation (NYSE:CNMD – Get Free Report) has received an average rating of “Hold” from the five analysts that are presently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among analysts […] - 2025-06-24 02:36:59
CONMED Corporation (NYSE:CNMD) Shares Acquired by Blue Trust Inc.: Blue Trust Inc. raised its position in shares of CONMED Corporation (NYSE:CNMD – Free Report) by 49.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,140 shares of the company’s stock after purchasing an additional 1,702 shares during the period. Blue Trust Inc.’s […] - 2025-06-23 05:00:54
CONMED Co. (NYSE:CNMD) Shares Sold by Fifth Third Bancorp: Fifth Third Bancorp decreased its position in shares of CONMED Co. (NYSE:CNMD – Free Report) by 16.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,815 shares of the company’s stock after selling 2,881 shares during the […] - 2025-06-17 04:51:02
CONMED (NYSE:CNMD) Lowered to Hold Rating by Needham & Company LLC: Needham & Company LLC cut shares of CONMED (NYSE:CNMD – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning, Marketbeat.com reports. They currently have $61.00 price objective on the stock. CNMD has been the topic of several other reports. Wells Fargo & Company lowered […] - 2025-06-13 05:52:55
Harbor Capital Advisors Inc. Buys New Position in CONMED Co. (NYSE:CNMD): Harbor Capital Advisors Inc. bought a new stake in shares of CONMED Co. (NYSE:CNMD – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 21,343 shares of the company’s stock, valued at approximately $1,289,000. Harbor Capital Advisors Inc. owned about […] - 2025-06-13 05:16:51
Rhumbline Advisers Has $5.68 Million Position in CONMED Co. (NYSE:CNMD): Rhumbline Advisers trimmed its position in shares of CONMED Co. (NYSE:CNMD – Free Report) by 0.4% during the first quarter, Holdings Channel.com reports. The fund owned 93,990 shares of the company’s stock after selling 334 shares during the quarter. Rhumbline Advisers’ holdings in CONMED were worth $5,676,000 as of its most recent SEC filing. Other […] - 2025-06-13 04:40:51
GAMMA Investing LLC Buys 78,808 Shares of CONMED Co. (NYSE:CNMD): GAMMA Investing LLC raised its position in shares of CONMED Co. (NYSE:CNMD – Free Report) by 10,855.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 79,534 shares of the company’s stock after purchasing an additional 78,808 shares during the period. […] - 2025-06-11 04:56:54
CONMED Co. (NYSE:CNMD) Stock Position Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC: UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of CONMED Co. (NYSE:CNMD – Free Report) by 16.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 78,121 shares of the company’s stock after purchasing an additional 11,059 shares during the quarter. UBS AM a […] - 2025-06-03 05:13:07
Head-To-Head Analysis: CONMED (NYSE:CNMD) and Heart Tronics (OTCMKTS:HRTT): CONMED (NYSE:CNMD – Get Free Report) and Heart Tronics (OTCMKTS:HRTT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Valuation & Earnings This table compares CONMED and Heart […] - 2025-06-02 02:50:53
3,248 Shares in CONMED Co. (NYSE:CNMD) Acquired by Quantinno Capital Management LP: Quantinno Capital Management LP bought a new stake in CONMED Co. (NYSE:CNMD – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 3,248 shares of the company’s stock, valued at approximately $222,000. Several other institutional investors and hedge funds have also bought […] - 2025-05-28 05:06:48
CONMED Co. (NYSE:CNMD) Receives Consensus Rating of “Hold” from Brokerages: CONMED Co. (NYSE:CNMD – Get Free Report) has earned an average rating of “Hold” from the five ratings firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among […] - 2025-05-27 02:49:01
ProShare Advisors LLC Increases Stock Position in CONMED Co. (NYSE:CNMD): ProShare Advisors LLC increased its position in shares of CONMED Co. (NYSE:CNMD – Free Report) by 44.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,300 shares of the company’s stock after purchasing an additional 2,865 shares during the quarter. ProShare Advisors […] - 2025-05-26 06:22:51
Captrust Financial Advisors Purchases 3,311 Shares of CONMED Co. (NYSE:CNMD): Captrust Financial Advisors lifted its stake in shares of CONMED Co. (NYSE:CNMD – Free Report) by 53.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 9,562 shares of the company’s stock after buying an additional 3,311 shares during the quarter. Captrust Financial Advisors’ holdings […] - 2025-05-18 05:49:17
Northern Trust Corp Buys 47,078 Shares of CONMED Co. (NYSE:CNMD): Northern Trust Corp increased its stake in CONMED Co. (NYSE:CNMD – Free Report) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 356,765 shares of the company’s stock after acquiring an additional 47,078 shares during the period. Northern Trust […] - 2025-05-13 05:28:52
CONMED (NYSE:CNMD) Lowered to “Hold” Rating by StockNews.com: StockNews.com lowered shares of CONMED (NYSE:CNMD – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday. Other equities analysts also recently issued reports about the stock. Wells Fargo & Company cut their price target on shares of CONMED from $70.00 to $57.00 and set an “equal […] - 2025-05-09 04:36:56
First Trust Advisors LP Has $1.46 Million Holdings in CONMED Co. (NYSE:CNMD): First Trust Advisors LP raised its position in shares of CONMED Co. (NYSE:CNMD – Free Report) by 33.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 21,255 shares of the company’s stock after buying an additional 5,309 shares during the period. First Trust Advisors LP’s holdings in CONMED were worth $1,455,000 at […] - 2025-05-07 05:15:06
Brokerages Set CONMED Co. (NYSE:CNMD) Target Price at $62.20: Shares of CONMED Co. (NYSE:CNMD – Get Free Report) have been assigned an average recommendation of “Hold” from the five ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target […] - 2025-05-05 02:49:07
CONMED (NYSE:CNMD) Shares Gap Up After Strong Earnings: CONMED Co. (NYSE:CNMD – Get Free Report)’s share price gapped up before the market opened on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $49.11, but opened at $55.00. CONMED shares last traded at $56.58, with a volume of 40,475 shares. The company reported $0.95 earnings per […] - 2025-05-02 04:32:50
Implied IJS Analyst Target Price: $122: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-25 07:58:46

iShares US Medical Devices UCITS ETF CNMD holdings

Date	Number of CNMD Shares Held	Base Market Value of CNMD Shares	Local Market Value of CNMD Shares	Change in CNMD Shares Held	Change in CNMD Base Value	Current Price per CNMD Share Held	Previous Price per CNMD Share Held
2025-09-18 (Thursday)	4,066	USD 209,074	USD 209,074	0	USD 3,822	USD 51.4201	USD 50.4801
2025-09-17 (Wednesday)	4,066	USD 205,252	USD 205,252	0	USD -9,189	USD 50.4801	USD 52.74
2025-09-16 (Tuesday)	4,066	USD 214,441	USD 214,441
2025-09-15 (Monday)	4,066	USD 210,578	USD 210,578
2025-09-12 (Friday)	4,066	USD 215,091	USD 215,091
2025-09-11 (Thursday)	4,066	USD 219,767	USD 219,767
2025-09-10 (Wednesday)	4,066	USD 214,725	USD 214,725
2025-09-09 (Tuesday)	4,066	USD 219,483	USD 219,483
2025-09-08 (Monday)	4,066	USD 218,873	USD 218,873

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CNMD by Blackrock for IE00BMX0DF60

Show aggregate share trades of CNMD

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-27 SELL -68 52.170* 61.55 Profit of 4,186 on sale
2025-06-12 BUY 99 54.970* 62.15
2025-06-10 SELL -528 59.370* 62.21 Profit of 32,845 on sale
2025-06-09 SELL -627 59.040* 62.23 Profit of 39,019 on sale
2025-05-30 SELL -66 56.750* 62.51 Profit of 4,126 on sale
2025-05-19 BUY 33 60.270* 62.91
2025-05-09 SELL -170 57.080* 63.10 Profit of 10,728 on sale
2025-04-23 SELL -35 49.710* 64.28 Profit of 2,250 on sale
2025-04-17 SELL -35 48.590* 64.98 Profit of 2,274 on sale
2025-04-10 BUY 272 52.290* 65.83
2025-04-04 SELL -68 56.240* 66.34 Profit of 4,511 on sale
2025-04-02 SELL -68 60.430* 66.42 Profit of 4,516 on sale
2025-03-31 SELL -102 60.390* 66.58 Profit of 6,791 on sale
2025-03-19 SELL -33 58.910* 67.35 Profit of 2,223 on sale
2025-02-28 SELL -66 59.170* 68.84 Profit of 4,544 on sale
2025-02-05 BUY 102 74.000* 70.78
2025-02-04 BUY 136 72.880* 70.73
2025-01-29 SELL -34 70.390* 70.69 Profit of 2,404 on sale
2025-01-23 SELL -34 68.490* 70.79 Profit of 2,407 on sale
2025-01-02 SELL -66 67.350* 70.90 Profit of 4,679 on sale
2024-12-04 BUY 99 73.800* 70.41
2024-12-03 SELL -33 74.930* 70.25 Profit of 2,318 on sale
2024-12-02 SELL -396 75.960* 70.03 Profit of 27,731 on sale
2024-11-29 SELL -660 74.040* 69.87 Profit of 46,112 on sale
2024-11-27 SELL -99 73.160* 69.58 Profit of 6,888 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-27	SELL	-68	52.170*	61.55 Profit of 4,186 on sale
2025-06-12	BUY	99	54.970*	62.15
2025-06-10	SELL	-528	59.370*	62.21 Profit of 32,845 on sale
2025-06-09	SELL	-627	59.040*	62.23 Profit of 39,019 on sale
2025-05-30	SELL	-66	56.750*	62.51 Profit of 4,126 on sale
2025-05-19	BUY	33	60.270*	62.91
2025-05-09	SELL	-170	57.080*	63.10 Profit of 10,728 on sale
2025-04-23	SELL	-35	49.710*	64.28 Profit of 2,250 on sale
2025-04-17	SELL	-35	48.590*	64.98 Profit of 2,274 on sale
2025-04-10	BUY	272	52.290*	65.83
2025-04-04	SELL	-68	56.240*	66.34 Profit of 4,511 on sale
2025-04-02	SELL	-68	60.430*	66.42 Profit of 4,516 on sale
2025-03-31	SELL	-102	60.390*	66.58 Profit of 6,791 on sale
2025-03-19	SELL	-33	58.910*	67.35 Profit of 2,223 on sale
2025-02-28	SELL	-66	59.170*	68.84 Profit of 4,544 on sale
2025-02-05	BUY	102	74.000*	70.78
2025-02-04	BUY	136	72.880*	70.73
2025-01-29	SELL	-34	70.390*	70.69 Profit of 2,404 on sale
2025-01-23	SELL	-34	68.490*	70.79 Profit of 2,407 on sale
2025-01-02	SELL	-66	67.350*	70.90 Profit of 4,679 on sale
2024-12-04	BUY	99	73.800*	70.41
2024-12-03	SELL	-33	74.930*	70.25 Profit of 2,318 on sale
2024-12-02	SELL	-396	75.960*	70.03 Profit of 27,731 on sale
2024-11-29	SELL	-660	74.040*	69.87 Profit of 46,112 on sale
2024-11-27	SELL	-99	73.160*	69.58 Profit of 6,888 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CNMD

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	68,144	0	99,945	68.2%
2025-09-18	77,494	0	120,846	64.1%
2025-09-17	139,790	0	185,901	75.2%
2025-09-16	54,278	0	71,515	75.9%
2025-09-15	58,359	0	87,783	66.5%
2025-09-12	46,347	0	67,090	69.1%
2025-09-11	68,743	358	90,404	76.0%
2025-09-10	123,682	0	204,778	60.4%
2025-09-09	73,987	0	132,930	55.7%
2025-09-08	81,426	0	120,967	67.3%
2025-09-05	94,499	0	154,119	61.3%
2025-09-04	112,230	0	133,235	84.2%
2025-09-03	98,662	0	117,542	83.9%
2025-09-02	82,407	5,100	106,167	77.6%
2025-08-29	60,985	0	78,378	77.8%
2025-08-28	50,420	0	78,519	64.2%
2025-08-27	44,450	0	59,386	74.8%
2025-08-26	59,875	555	78,736	76.0%
2025-08-25	62,072	0	88,420	70.2%
2025-08-22	56,231	0	204,338	27.5%
2025-08-21	102,061	0	145,556	70.1%
2025-08-20	86,189	1,000	122,030	70.6%
2025-08-19	50,162	0	82,386	60.9%
2025-08-18	92,359	0	128,865	71.7%
2025-08-15	58,318	0	86,602	67.3%
2025-08-14	96,827	0	139,311	69.5%
2025-08-13	95,818	0	147,456	65.0%
2025-08-12	89,026	0	137,732	64.6%
2025-08-11	243,784	0	351,664	69.3%
2025-08-08	131,608	0	234,027	56.2%
2025-08-07	123,847	0	965,493	12.8%
2025-08-06	90,979	0	152,783	59.5%
2025-08-05	157,809	0	209,848	75.2%
2025-08-04	87,393	627	150,855	57.9%
2025-08-01	159,424	0	234,656	67.9%
2025-07-31	324,519	0	502,750	64.5%
2025-07-30	124,626	126	228,986	54.4%
2025-07-29	69,695	0	120,133	58.0%
2025-07-28	115,529	0	178,883	64.6%
2025-07-25	42,761	0	81,837	52.3%
2025-07-24	63,837	0	113,967	56.0%
2025-07-23	136,813	0	257,540	53.1%
2025-07-22	73,730	232	265,210	27.8%
2025-07-21	67,711	2,300	172,556	39.2%
2025-07-18	76,749	0	161,067	47.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam